| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001068700A3 Regulation of human substance p-like g protein-coupled receptor |
| 03/21/2002 | WO2001068568A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001068034A3 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 03/21/2002 | WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors |
| 03/21/2002 | WO2001064165A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001055106A3 Novel melanocortin receptor agonists and antagonists |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001051510A3 G-csf conjugates |
| 03/21/2002 | WO2001041797A3 Systemic immune response induced by mucosal administration of l ipid-tailed polypeptides without adjuvant |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035243 Drug complexes |
| 03/21/2002 | US20020035161 O/W emulsions comprising micronized biologically active agents |
| 03/21/2002 | US20020035147 Nervous system, psychological disorders |
| 03/21/2002 | US20020035144 Solubility, bioavailability; antiinflammatory agents |
| 03/21/2002 | US20020035140 1-(pyrrlolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/21/2002 | US20020035127 Phenylalanine derivatives |
| 03/21/2002 | US20020035118 Low molecular weight cell, bone marrow and immune stimulants |
| 03/21/2002 | US20020035114 Substituted dimeric compounds |
| 03/21/2002 | US20020035108 Method for treating allergies |
| 03/21/2002 | US20020035104 Integrin receptor inhibitors |
| 03/21/2002 | US20020035102 Azetidine derivatives, their preparation and medicaments containing them |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | US20020035077 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034534 Receptor loading dosage form containing therapeutic agent and extended-release dosage form containing therapeutic agent administered concurrently |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034514 Administering microsphere of immunogens; enteric overcoatings |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034504 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | DE10138935A1 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen Synthetic compounds from non-mucin or its conjugated with a carrier compounds |
| 03/21/2002 | DE10045047A1 Arzneimittel enthaltend aktiviertes Antithrombin III Medicines containing activated antithrombin III |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422575A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422376A1 Isoxazoles and their use as inhibitors of erk |
| 03/21/2002 | CA2422076A1 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | CA2422033A1 Method for treating inflammation |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421966A1 Remedies for ischemic diseases |
| 03/21/2002 | CA2421279A1 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2420450A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188827A1 Processes for the fusion of dendritic cells with tumor cells and media for such processes |
| 03/20/2002 | EP1188765A1 Mechanism oriented inhibitors of dipeptidyl peptidase I |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1187624A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 03/20/2002 | EP1187620A1 Antisense modulation of b7 protein expression |
| 03/20/2002 | EP1187615A2 Immunosurpressive effects of pteridine derivatives |
| 03/20/2002 | EP1187613A1 Amide substituted imidazoquinolines |
| 03/20/2002 | EP1187605A1 Non-malignant disease treatment with ras antagonists |
| 03/20/2002 | EP1156040A4 2,4-dioxo-5-arylidenimino-1,3-pyrimidines |
| 03/20/2002 | EP1077687B1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof |
| 03/20/2002 | CN1341103A Pyridazin-3-one derivatives and medicines containing the same |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/20/2002 | CN1341028A New use of melagatran |
| 03/20/2002 | CN1341027A Inhibitors for use in hemostasis and immune function |
| 03/20/2002 | CN1341026A Small peptides and methods for treatment of asthma and inflammation |
| 03/20/2002 | CN1340357A Chinese medicine for reforcing vital energy of kidney |
| 03/20/2002 | CN1081058C Chinese-medicinal band for therapy |
| 03/19/2002 | US6359181 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 03/19/2002 | US6359145 Imidazole compounds |
| 03/19/2002 | US6359003 Fumaric acid alkyl esters for suppressing host versus graft reaction |
| 03/19/2002 | US6358973 For therapy of allergic or inflammatory disease |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358969 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 03/19/2002 | US6358962 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |